Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Adicet Bio Inc
(NQ:
ACET
)
1.530
+0.010 (+0.66%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Adicet Bio Inc
< Previous
1
2
3
4
Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 27, 2023
Via
Benzinga
Why American Equity Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
June 27, 2023
Gainers
Via
Benzinga
Adicet Bio Stock Is Falling Premarket - Here's Why
June 27, 2023
Adicet Bio Inc (NASDAQ: ACET) shared safety and efficacy data from its Phase 1 study of ADI-001 for relapsed or refractory aggressive B-cell
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
June 27, 2023
It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on Tuesday morning!
Via
InvestorPlace
Adicet Bio's Cancer Candidate Shows Anti-Tumor Activity In Preclinical Study
May 18, 2023
Adicet Bio Inc (NASDAQ: ACET)
Via
Benzinga
MoonLake Immunotherapeutics, Applied Digital And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
June 27, 2023
U.S. stock futures traded slightly higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
June 15, 2023
On Thursday, 64 companies achieved new lows for the year.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
June 01, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2023
June 01, 2023
Via
Benzinga
7 Biotech Stocks With Huge Return Potential for Long-Term Investors
April 26, 2023
Although a wildly speculative sector, the low-cost, high-potential biotech stocks to buy and hold may deliver the goods for gamblers.
Via
InvestorPlace
7 Biotech Stocks That Could Be the Next Big Thing
March 15, 2023
Although speculation might be a tough call at this juncture, these biotech stocks and their underlying science might be compelling enough.
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
February 15, 2023
On Wednesday, 35 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
January 10, 2023
Tuesday's session saw 16 companies set new 52-week lows.
Via
Benzinga
Peering Into Adicet Bio's Recent Short Interest
December 13, 2022
Adicet Bio's (NASDAQ:ACET) short percent of float has risen 29.62% since its last report. The company recently reported that it has 4.02 million shares sold short, which is 12.56% of all regular shares...
Via
Benzinga
Dow Surges Over 250 Points; Weber Shares Spike Higher
December 12, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 250 points on Monday
Via
Benzinga
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
December 12, 2022
Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.
Via
Benzinga
Stocks Hold Gains Ahead Of Tuesday's Economic Flurry
December 12, 2022
The major indexes are continuing their move higher this afternoon, as investors await tomorrow's release of November's consumer price index (CPI) data.
Via
Talk Markets
12 Health Care Stocks Moving In Monday's Intraday Session
December 12, 2022
Via
Benzinga
Crude Oil Rises Sharply; Adicet Bio Shares Plunge
December 12, 2022
U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 250 points on Monday
Via
Benzinga
RH, HUYA, Bilibili And Some Other Big Stocks Moving Lower On Monday
December 12, 2022
U.S. stocks traded higher, with the Dow Jones jumping more than 200 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Adicet Bio Shares Fall After Underwhelming Data From Non-Hodgkin's Lymphoma Study
December 12, 2022
Via
Benzinga
US Stocks Higher; Dow Rises Over 100 Points
December 12, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Monday
Via
Benzinga
Why Aptevo Therapeutics Shares Are Trading Higher By More Than 100%; Here Are 28 Stocks Moving Premarket
December 12, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 12, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
December 12, 2022
We're starting off the week with a look at the biggest pre-market stock movers traders need to know about for Monday morning!
Via
InvestorPlace
Gamma Delta T Cell Therapy Market Could Reach $4 Billion As Biotechs Race To Get Breakthrough Cancer Treatment Approved
November 22, 2022
This year, the World Health Organization (WHO) announced that cancer has become the leading cause of death worldwide, with the latest data showing that nearly 10 million deaths in 2020 were the result...
Via
Benzinga
Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday
November 17, 2022
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.
Via
Benzinga
Target, Holley, Ferroglobe And Other Big Losers From Wednesday
November 17, 2022
U.S. stocks closed mostly lower on Wednesday, with the Nasdaq Composite dropping around 175 points. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 25, 2022
Gainers Taysha Gene Therapies (NASDAQ:TSHA) stock increased by 36.4% to $2.06 during Tuesday's pre-market session. The market value of their outstanding shares is at $84.6 million.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2022
September 21, 2022
Upgrades For Berkshire Hathaway Inc (NYSE:BRK), Edward Jones upgraded the previous rating of Hold to Buy. Berkshire Hathaway earned $6312.49 in the second quarter, compared to $4399.91 in the year-ago...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.